标题
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
作者
关键词
Rifampicin, Isoniazid, Linezolid, Moxifloxacin, Therapeutic Drug Monitoring
出版物
DRUGS
Volume 74, Issue 8, Pages 839-854
出版商
Springer Nature
发表日期
2014-05-20
DOI
10.1007/s40265-014-0222-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Therapeutic Drug Monitoring in the Treatment of Active Tuberculosis
- (2016) Aylin Babalik et al. Canadian Respiratory Journal
- Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS
- (2014) D.H. Vu et al. TALANTA
- Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis
- (2013) Won-Jung Koh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients
- (2013) Erlina Burhan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis
- (2013) Rodney Dawson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis [Review article]
- (2013) T. J. Hwang et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Therapeutic drug monitoring in the treatment of tuberculosis: a retrospective analysis
- (2013) L. Van Tongeren et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Systematic review of clofazimine for the treatment of drug-resistant tuberculosis [Review article]
- (2013) M. Gopal et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients
- (2013) A. Babalık et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients
- (2013) Mohideen S. Jawahar et al. PLoS One
- High Rate of Hypothyroidism in Multidrug-Resistant Tuberculosis Patients Co-Infected with HIV in Mumbai, India
- (2013) Aristomo Andries et al. PLoS One
- New Susceptibility Breakpoints and the Regional Variability of MIC Distribution in Mycobacterium tuberculosis Isolates
- (2012) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
- (2012) D. H. Vu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
- (2012) Helen McIlleron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs
- (2012) Miroslav Dostalek et al. CLINICAL PHARMACOKINETICS
- In Vitro and In Vivo Modeling of Tuberculosis Drugs and its Impact on Optimization of Doses and Regimens
- (2012) Shashikant Srivastava et al. CURRENT PHARMACEUTICAL DESIGN
- NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
- (2012) Junichi Azuma et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
- (2012) Giovanni Sotgiu et al. EUROPEAN RESPIRATORY JOURNAL
- Antituberculosis therapy for 2012 and beyond
- (2012) Michael Lauzardo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort
- (2012) M. W. Carroll et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
- (2012) S. E. Dorman et al. JOURNAL OF INFECTIOUS DISEASES
- Dose-Dependent Activity of Pyrazinamide in Animal Models of Intracellular and Extracellular Tuberculosis Infections
- (2011) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience
- (2011) A. D. Pranger et al. EUROPEAN RESPIRATORY JOURNAL
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
- (2011) Timothy R. Sterling et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis
- (2011) L. Ben Mahmoud et al. PATHOLOGIE BIOLOGIE
- Therapeutic drug monitoring in the treatment of tuberculosis patients
- (2011) Cecile Magis-Escurra et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Limited-Sampling Strategies for Therapeutic Drug Monitoring of Moxifloxacin in Patients With Tuberculosis
- (2011) Arianna D Pranger et al. THERAPEUTIC DRUG MONITORING
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used
- (2010) J. G. Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
- (2010) Jan-Willem C. Alffenaar et al. CLINICAL PHARMACOKINETICS
- Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
- (2010) Jan-Willem C Alffenaar et al. THERAPEUTIC DRUG MONITORING
- Treatment of tuberculosis and optimal dosing schedules
- (2010) K. C. Chang et al. THORAX
- Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
- (2009) Susan E. Dorman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes
- (2009) R. Ruslami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis
- (2009) Catherine Boulanger et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- Tuberculosis and diabetes mellitus: convergence of two epidemics
- (2009) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- Therapeutic Drug Monitoring of Antimycobacterial Drugs in Patients with Both Tuberculosis and Advanced Human Immunodeficiency Virus Infection
- (2009) David P Holland et al. PHARMACOTHERAPY
- Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls
- (2009) Peter M Edelbroek et al. THERAPEUTIC DRUG MONITORING
- Risk factors for ethambutol optic toxicity
- (2009) Katherine Anne Talbert Estlin et al. INTERNATIONAL OPHTHALMOLOGY
- Repeated Administration of High-Dose Intermittent Rifapentine Reduces Rifapentine and Moxifloxacin Plasma Concentrations
- (2008) K. Dooley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Concomitant Use of Voriconazole and Rifabutin in a Patient with Multiple Infections
- (2008) Joshua N Schwiesow et al. PHARMACOTHERAPY
- Using Animal Models to Develop New Treatments for Tuberculosis
- (2008) Eric Nuermberger SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs
- (2008) G.R. Davies et al. TUBERCULOSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now